Skip to main content
SpringerLink
Log in

The treatment of hypertension: New lamps for old?

  • When to Start Hypertension Therapy
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Meta-analysis of clinical trials does not help the clinician to treat individual patients. A general conclusion that the reduction of high blood pressure is beneficial has to be matched by specific information about the level of blood pressure that is acceptable and about the effect of particular doses of specific drugs. Results obtained from trials of “old-fashioned” antihypertensive drugs cannot confidently be extrapolated to “modern” agents. Sufficient data do not exist to encourage universal drug treatment for patients with “mild” hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335: 827–838.

    Google Scholar 

  2. Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment for hypertension. A review. Hypertension 1989;13(Suppl I):I36-I44.

    Google Scholar 

  3. European Working Party on High Blood Pressure in the Elderly. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60*. Lancet 1986;2:589–592.

    Google Scholar 

  4. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981;2:539–543. 6.

    Google Scholar 

  5. Cameron HA, Ramsay LE. Ketanserin in essential hypertension: a double-blind, placebo-controlled study. Postgrad Med J 1985;61:583–586.

    Google Scholar 

  6. Prevention of Atherosclerotic Complications with Ketanserin Trial Group. Prevention of atherosclerotic complications: controlled trial of ketanserin. Br Med J 1989;298: 424–430.

    Google Scholar 

  7. Payer L. Medicine & Culture: Varieties of Treatment in the United States, England, West Germany, and France. New York: Henry Holt and Company, 1988.

    Google Scholar 

  8. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results. Br Med J 1985;291:97–104.

    Google Scholar 

  9. McVeigh G, Galloway D, Johnston D. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. Br Med J 1988;297:95–97.

    Google Scholar 

  10. European Working Party on High Blood Pressure in the Elderly. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial. Lancet 1985;1:1349–1354.

    Google Scholar 

  11. Floras JS, Jones JV, Hassan MO, et al. Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet 1981;2:107–109.

    Google Scholar 

  12. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987;1:581–584.

    Google Scholar 

  13. Wessely S, Nickson J, Cox B. Symptoms of low blood pressure: A population study. Br Med J 1990;301:362–365.

    Google Scholar 

  14. Editorial. How far to lower blood pressure? Lancet 1987;2:251–252.

  15. Keeler EB, Brook RH, Goldberg GA, et al. How free care reduced hypertension of participants in the Rand health insurance experiment. Rand Health Insurance Experiment Series, October, 1985.

  16. A report by the management committee of the Australian therapeutic trial in mild hypertension. Untreated mild hypertension. Lancet 1982;1:185–191.

  17. Wilcox RG, Bennett T, Brown AM, MacDonald IA. Is exercise good for high blood pressure? Br Med J 1982;285: 767–769.

    Google Scholar 

  18. Puddey IB, Beilin LJ, Bandongen R. Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial. Lancet 1987;1:647–650.

    Google Scholar 

  19. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br Med J 1988;297:319–321.

    Google Scholar 

  20. Grobbee DE, Hofman A. Dose sodium restriction lower blood pressure? Br Med J 1986;293:27–29.

    Google Scholar 

  21. Swales JD. Salt saga continued. Salt has only small importance in hypertension [editorial]. Br Med J 1988;297: 307–309.

    Google Scholar 

  22. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982;248:1465–1477.

    Google Scholar 

  23. Pickering G. Hyperpiesis: High blood-pressure without evident cause: Essential hypertension. Br Med J 1965;2:959–968 and 1021–1026.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Queen's Medical Centre, University Hospital, NG7 2UH, Nottingham, UK

    J. R. Hampton

Authors
  1. J. R. Hampton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hampton, J.R. The treatment of hypertension: New lamps for old?. Cardiovasc Drug Ther 5, 983–985 (1991). https://doi.org/10.1007/BF00143524

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00143524

Key Words

Search

Navigation